6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one,
Bicuculline,
(+)-Bicuculline,
bicuculline,
d-Bicuculline,
485-49-4,
Bicculine,
Bicucullin,
Bicuculline (+),
UNII-Y37615DVKC,
NSC 32192,
C20H17NO6,
EINECS 207-619-7,
BRN 0098786,
CHEBI:3092,
CHEMBL417990,
Y37615DVKC,
(6R)-6-[(5S)-6-methyl-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-5-yl]furo[3,4-e][1,3]benzodioxol-8(6H)-one,
NSC32192,
MFCD00005006,
Furo(3,4-e)-1,3-benzodioxol-8(6H)-one, 6-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (R-(R*,S*))-,
(6R)-6-((5S)-6-methyl(5,6,7,8-tetrahydro-2H-1,3-dioxolano[4,5-g]isoquinolin-5- yl))-6-hydro-2H-1,3-dioxoleno[4,5-e]isobenzofuran-8-one,
(6R)-6-[(5S)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6H-furo[3,4-g][1,3]benzodioxol-8-one,
(R)-6-((S)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)isobenzofuro[5,4-d][1,3]dioxol-8(6H)-one,
Furo[3,4-e]-1,3-benzodioxol-8(6H)-one, 6-[(5S)-5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-, (6R)-,
SR-01000075252,
Bicuculline,(+),
Prestwick_96,
Furo(3,4-e)-1,3-benzodioxol-8(6H)-one, 6-((5S)-5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)-, (6R)-,
AC1L1URW,
Prestwick0_000589,
Prestwick1_000589,
Prestwick2_000589,
Prestwick3_000589,
Biomol-NT_000252,
(+)-Bicuculline, 98%,
SCHEMBL8222,
Lopac0_000234,
BSPBio_000438,
4-27-00-06900 (Beilstein Handbook Reference),
MLS002153892,
DivK1c_000609,
SPBio_002657,
BPBio1_000482,
BPBio1_000794,
GTPL2312,
DTXSID3042687,
HMS501O11,
KBio1_000609,
AOB5192,
NINDS_000609,
HMS1569F20,
HMS2096F20,
HMS2235H18,
HMS3266A07,
HMS3652N20,
HMS3678D19,
BCP04180,
HY-N0219,
BDBM50000693,
NSC-32192,
PDSP2_000138,
s7071,
ZINC19899011,
AKOS024282673,
API0002224,
CCG-204329,
CS-5493,
DB11562,
IDI1_000609,
NCGC00017385-06,
(+)-Bicuculline, >=97.0% (TLC),
6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo(4,5-g)isoquinolin-5-yl)furo(3,4-e)1,3-benzodioxol-8(6H)one,
AN-45228,
AS-17471,
LS-70680,
SC-17991,
SMR001233241,
ST057559,
ST057706,
AB0019776,
FT-0080946,
N1592,
SW196408-2,
V0271,
A12590,
B 9130,
C09364,
485B494,
C-21058,
SR-01000075252-1,
SR-01000075252-4,
SR-01000075252-5,
WLN: T C566 DO FO KN EH&&TJ K1 J- ET B565 CVO JO LO EH KHJ,
(6R)-6-[(5S)-5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo[4,5-g]lisoquinolin-5-yl]furo[3,4-e]-1,3-benzodioxol-8(6H)-one,
(6R)-6-[(5S)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6H-furo[3,4-e][1,3]benzodioxol-8-one,
(6R)-6-[(5S)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6H-furo[4,3-g][1,3]benzodioxol-8-one,
(bicuculline) 6-Methyl-5-(8-oxo-6,8-dihydro-furo[3'',4'':3,4]benzo[1,2-d][1,3]dioxol-6-yl)-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-6-ium,
(R)-6-((S)-6-Methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6H-furo[3'',4'':3,4]benzo[1,2-d][1,3]dioxol-8-one,
[R-(R*,S*)]-6-(5,6,7,8-Tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)furo[3,4-e]-1,3-benzodioxol-8(6H)-one,
6-((5S)-6-methyl-5,6,7,8-tetrahydro-2H-1,3-dioxoleno[4,5-g]isoquinolin-5-yl)-6 -hydro-2H-1,3-dioxoleno[4,5-e]isobenzofuran-8-one,
6-(6-Methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6H-furo[3'',4'':3,4]benzo[1,2-d][1,3]dioxol-8-one,
6-(6-Methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6H-furo[3'',4'':3,4]benzo[1,2-d][1,3]dioxol-8-one (Bicuculline),
6-(6-Methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6H-furo[3'',4'':3,4]benzo[1,2-d][1,3]dioxol-8-one(bicuculline),
Furo[3,3-benzodioxol-8(6H)-one, 6-(5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl)-, [R-(R*,S*)]-,
Furo[3,4-e]-1,3-benzodioxol-8(6H)-one,6-[(5S)-5,6,7,8-tetrahydro-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-5-yl]-, (6R)-,
H0Z,
bicuculline methochloride,
Bicuculline methiodide,
D00LBX,
CID10237,
C20-H17-N-O6,
ACN-035748,
B1890,
B-2400,
D001640,
( )-Bicuculline, 99%, a GABAA antagonist - 100MG 100mg,
56083-00-2,
BIC,